🇺🇸 FDA
Pipeline program

Bioequivalence of Lisdexamfetamine dimesylate 10 mg/mL Oral Solution in Healthy Participants Under Fasting Conditions.

BLCL-LIS-EU-03

Phase 1 other active

Quick answer

Bioequivalence of Lisdexamfetamine dimesylate 10 mg/mL Oral Solution in Healthy Participants Under Fasting Conditions. for No medical condition. is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
No medical condition.
Phase
Phase 1
Modality
other
Status
active

Clinical trials